Evidence map›Paper›PMID 23616621›Full record

ArticleCirculation research2013

Macrophage-derived matrix vesicles: an alternative novel mechanism for microcalcification in atherosclerotic plaques.

Sophie E P New, Claudia Goettsch, Masanori Aikawa, Julio F Marchini, Manabu Shibasaki, Katsumi Yabusaki, Peter Libby, Catherine M Shanahan, Kevin Croce, Elena Aikawa

Open access · bronzeAbstract readVideo-Audio Media
In one paragraph

Article in Circulation research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 253 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
253citing papers in PubMed, 2 pooled it
16.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

253 citing papers in PubMed, 2 syntheses or guidelines pooled it, 424 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Taking a closer look at matrix vesicle biogenesis.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2025
    Review
  19. Review
  20. Review

193 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 2 countries.

Sophie E P NewCenter for Interdisciplinary Cardiovascular Sciences, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Claudia Goettsch
Masanori Aikawa
Julio F Marchini
Manabu Shibasaki
Katsumi Yabusaki
Peter Libby
Catherine M Shanahan
Kevin Croce
Elena Aikawa
King's College London · GB

Funding

Molecular Determinants of Arterial Remodeling in AtherogenesisR01HL080472 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LIBBY, PETER · 2005 to 2018
$5.0M
Aortic valve microcalcificationR01HL114805 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI AIKAWA, ELENA · 2012 to 2016
$2.1M
MRP-14, Platelets and AtherothrombosisK08HL086672 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI CROCE, KEVIN J · 2008 to 2012
$682k
British Heart Foundation RG/11/14/29056NHLBI NIH HHS K08 HL086672NHLBI NIH HHS K08HL086672-02NHLBI NIH HHS R01 HL080472NHLBI NIH HHS R01 HL114805NHLBI NIH HHS R01HL114805NHLBI NIH HHS R01HL80472
6 · The paper itself

Abstract

rationaleWe previously showed that early calcification of atherosclerotic plaques associates with macrophage accumulation. Chronic renal disease and mineral imbalance accelerate calcification and the subsequent release of matrix vesicles (MVs), precursors of microcalcification.

objectiveWe tested the hypothesis that macrophage-derived MVs contribute directly to microcalcification. METHODS AND

resultsMacrophages associated with regions of calcified vesicular structures in human carotid plaques (n=136 patients). In vitro, macrophages released MVs with high calcification and aggregation potential. MVs expressed exosomal markers (CD9 and TSG101) and contained S100A9 and annexin V. Silencing S100A9 in vitro and genetic deficiency in S100A9-/- mice reduced MV calcification, whereas stimulation with S100A9 increased calcification potential. Externalization of phosphatidylserine after Ca/P stimulation and interaction of S100A9 and annexin V indicated that a phosphatidylserine-annexin V-S100A9 membrane complex facilitates hydroxyapatite nucleation within the macrophage-derived MV membrane.

conclusionsOur results support the novel concept that macrophages release calcifying MVs enriched in S100A9 and annexin V, which contribute to accelerated microcalcification in chronic renal disease.

Indexed as

AnimalsAnnexin A5Apolipoproteins ECalcinosisCalciumCalgranulin BCarotid Artery DiseasesCell LineCytoplasmic VesiclesDurapatiteHumansMacrophagesMacrophages, PeritonealMembrane LipidsMembrane ProteinsMiceAnnexin A5Apolipoproteins ECalciumCalgranulin BDurapatiteMembrane LipidsMembrane ProteinsPhosphatidylserinesPhosphorusRNA, Small InterferingS100A9 protein, mouseatherosclerosiscalcificationextracellular vesiclesinflammationmacrophagesrenal insufficiency, chronicrupture

Identifiers

PMID23616621
PMCPMC3703850
OpenAlexW4251327626

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.